Search research articles
Contact Us
Filters
Showing results (61-70 of 343) with videos related to
Page
of 35
Sort By:
Psychiatric Genetics
|
January 1, 1994
Estimating the morbidity risk for diseases having a variable age at onset
S V Faraone, W J Chen, M T Tsuang
Journal of Clinical Psychopharmacology
|
October 1, 1989
Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics
A S Young, S V Faraone, W A Brown
The Journal of Clinical Psychiatry
|
March 1, 1990
Retrospective assessment of DSM-III attention deficit disorder in nonreferred individuals
J Biederman, S V Faraone, D Knee, et al.
Memory & Cognition
|
January 1, 1984
Information integration in price-quality tradeoffs: the effect of missing information
I P Levin, R D Johnson, S V Faraone
Biological Psychiatry
|
September 9, 2000
Towards the prevention of schizophrenia
M T Tsuang, W S Stone, S V Faraone
Harvard Review of Psychiatry
|
December 1, 1999
Schizophrenia: a review of genetic studies
M T Tsuang, W S Stone, S V Faraone
Journal of Child and Adolescent Psychopharmacology
|
October 29, 2000
Sleep disturbances associated with attention deficit hyperactivity disorder: the impact of psychiatric comorbidity and pharmacotherapy
E Mick, J Biederman, J Jetton, et al.
Harvard Review of Psychiatry
|
March 1, 1994
Is attention-deficit hyperactivity disorder in adults a valid disorder?
T Spencer, J Biederman, T Wilens, et al.
Statistics in Medicine
|
March 1, 1992
Mathematical models of complex dose-response relationships: implications for experimental design in psychopharmacologic research
S V Faraone, J C Simpson, W A Brown
Molecular Psychiatry
|
November 1, 2003
Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia
S J Glatt, S V Faraone, M T Tsuang
Page
of 35
Search research articles
Search
Showing results (61-70 of 343) with videos related to
Sort By:
Page
of 35
Psychiatric Genetics
|
January 1, 1994
Estimating the morbidity risk for diseases having a variable age at onset
S V Faraone, W J Chen, M T Tsuang
Journal of Clinical Psychopharmacology
|
October 1, 1989
Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics
A S Young, S V Faraone, W A Brown
The Journal of Clinical Psychiatry
|
March 1, 1990
Retrospective assessment of DSM-III attention deficit disorder in nonreferred individuals
J Biederman, S V Faraone, D Knee, et al.
Memory & Cognition
|
January 1, 1984
Information integration in price-quality tradeoffs: the effect of missing information
I P Levin, R D Johnson, S V Faraone
Biological Psychiatry
|
September 9, 2000
Towards the prevention of schizophrenia
M T Tsuang, W S Stone, S V Faraone
Harvard Review of Psychiatry
|
December 1, 1999
Schizophrenia: a review of genetic studies
M T Tsuang, W S Stone, S V Faraone
Journal of Child and Adolescent Psychopharmacology
|
October 29, 2000
Sleep disturbances associated with attention deficit hyperactivity disorder: the impact of psychiatric comorbidity and pharmacotherapy
E Mick, J Biederman, J Jetton, et al.
Harvard Review of Psychiatry
|
March 1, 1994
Is attention-deficit hyperactivity disorder in adults a valid disorder?
T Spencer, J Biederman, T Wilens, et al.
Statistics in Medicine
|
March 1, 1992
Mathematical models of complex dose-response relationships: implications for experimental design in psychopharmacologic research
S V Faraone, J C Simpson, W A Brown
Molecular Psychiatry
|
November 1, 2003
Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia
S J Glatt, S V Faraone, M T Tsuang
Page
of 35